Phase I study of VR647 in patients with Asthma

Trial Profile

Phase I study of VR647 in patients with Asthma

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Sep 2017

At a glance

  • Drugs Budesonide (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Sep 2017 According to a Vectura media release, dosing in this trial was completed in June 2017.
    • 06 Sep 2017 Status changed from planning to completed, according to a Vectura media release
    • 24 Jan 2017 According to a Vectura media release, this study is expected to initiate in H1 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top